A randomised, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of three dosing schedules of agalsidase alfa enzyme replacement therapy for Fabry disease.
| Image |  |
|---|---|
| Description | scientific article published on 28 April 2013 |
| Author/s |
author: Derralynn A Hughes Adam Jacobs |
| Publication date | April 28, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |